You can access the annual and quarterly cash flow statements of SBC Medical Group Holdings Inc to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q2
FY2023Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
369.90%22.51M
378.68%9.23M
811.51%51.96M
-516.73%-20.88M
-143.45%-8.34M
-47.62%1.93M
---7.30M
--5.01M
618.32%19.19M
12.46%3.68M
---3.70M
--3.27M
Net income from continuing operations
357.50%11.16M
-47.29%11.33M
118.08%14.28M
352.76%12.83M
-86.85%2.44M
14.62%21.49M
--6.55M
--2.83M
88.30%18.56M
192.16%18.75M
--9.86M
--6.42M
Operating gains losses
78.04%1.13M
6.71%670.43K
-95.79%673.68K
-26.72%746.21K
-23.45%636.10K
-38.31%628.30K
--15.99M
--1.02M
-78.12%830.95K
-63.59%1.02M
--3.80M
--2.80M
Deferred tax
-892.08%-3.46M
-115.49%-1.09M
69.20%-3.78M
41.39%1.65M
114.74%436.76K
2045.81%7.02M
---12.26M
--1.17M
-215.11%-2.96M
91.18%-360.58K
--2.57M
---4.09M
Other non-cash items
-2.22%1.43M
117.96%1.39M
14.53%1.39M
60.14%1.27M
86.60%1.46M
-742.14%-7.74M
--1.22M
--795.10K
-21.95%781.99K
-5.70%1.20M
--1.00M
--1.28M
Change in working capital
187.59%11.78M
83.92%-3.15M
308.92%42.35M
-148.30%-35.84M
-815.83%-13.45M
-39.45%-19.60M
---20.27M
---14.43M
109.06%1.88M
-356.64%-14.06M
---20.73M
---3.08M
-Change in receivables
60.95%-6.84M
-406.03%-3.91M
6295.35%30.66M
-391.58%-9.96M
-567.52%-17.51M
-80.13%1.28M
---494.83K
--3.42M
227.50%3.75M
1605.99%6.44M
---2.94M
---427.41K
-Change in inventory
-21.58%-721.83K
456.17%442.64K
-220.32%-435.23K
388.69%983.02K
-199.49%-593.69K
-257.10%-124.28K
--361.73K
--201.15K
76.61%596.72K
99.26%-34.80K
--337.88K
---4.68M
-Change in prepaid expenses
86.55%3.57M
121.65%660.85K
250.65%2.55M
-126.60%-761.79K
184.06%1.91M
-507.88%-3.05M
---1.69M
--2.86M
-178.84%-2.28M
-89.48%748.27K
--2.89M
--7.11M
-Change in other current assets
48.91%-118.75K
-120.82%-66.27K
79.66%-273.45K
-101.26%-8.30K
65.75%-232.44K
196.82%318.35K
---1.34M
--659.25K
59.98%-678.61K
-155.15%-328.82K
---1.70M
--596.24K
-Change in other current liabilities
97.84%-102.76K
50.93%-1.52M
91.79%-2.17M
-21.66%-10.31M
38.36%-4.76M
-13.81%-3.09M
---26.42M
---8.47M
18.16%-7.73M
-501.75%-2.71M
---9.44M
--675.77K
Cash from non-recurring investing activities
Cash from operating activities
369.90%22.51M
378.68%9.23M
811.51%51.96M
-516.73%-20.88M
-143.45%-8.34M
-47.62%1.93M
---7.30M
--5.01M
618.32%19.19M
12.46%3.68M
---3.70M
--3.27M
Investing cash flow
Net cash from continuing investing activities
152.01%464.95K
27.18%548.87K
-740.69%-3.79M
-167.97%-851.48K
-203.82%-894.01K
-38.55%431.56K
--592.33K
--1.25M
-6.17%861.08K
-64.71%702.28K
--917.73K
--1.99M
Capital expenditures
-8.98%464.95K
-27.30%548.87K
56.64%927.81K
-85.93%176.27K
-40.81%510.80K
7.50%754.98K
--592.33K
--1.25M
-17.55%863.05K
-65.04%702.28K
--1.05M
--2.01M
Net cash flow from disposal of fixed assets
152.01%464.95K
27.18%548.87K
-740.69%-3.79M
-167.97%-851.48K
-203.82%-894.01K
-38.55%431.56K
--592.33K
--1.25M
-5.29%861.08K
122.59%702.28K
--909.14K
--315.50K
Net cash flow from intangible asset transactions
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
--8.59K
--1.67M
Net cash flow from business transactions
----
----
-90.74%-8.08M
---14.86M
----
----
---4.24M
----
----
----
--722.55K
----
Net cash flow from investment products
----
100.00%0.00
---19.94M
99.54%-1.51K
---441.66K
---635.14K
--0.00
---331.50K
----
----
---49.72K
----
Net cash flow from other investing activities
-93.53%1.03M
-76.29%20.84K
-95.70%12.76K
-65.90%1.85M
409.18%15.92M
104.69%87.90K
--296.56K
--5.44M
-397.66%-5.15M
-280.47%-1.88M
---1.03M
---493.08K
Cash from non-current investing activities
Net cash flow from investing activities
-96.55%565.23K
46.05%-528.02K
-432.30%-24.21M
-415.67%-12.16M
372.42%16.38M
71.16%-978.81K
---4.55M
--3.85M
-369.71%-6.01M
-36.69%-3.39M
---1.28M
---2.48M
Financing cash flow
Cash flow from continuous financing activities
-127.30%-1.96M
-557.11%-1.84M
74.16%19.82M
-1.07%11.57M
10491.67%7.18M
-596.99%-280.38K
--11.38M
--11.69M
98.67%-69.11K
-100.83%-40.23K
---5.19M
--4.85M
Net cash flow from debt Issuance/repayment
-2629.06%-1.99M
-588.45%-1.82M
59.68%19.25M
46978.56%14.17M
-153.01%-73.03K
-770.81%-264.33K
--12.06M
---30.23K
-101.20%-28.86K
-100.62%-30.35K
--2.41M
--4.86M
Net cash flow from common stock issuance/repurchase
----
----
--0.00
---2.58M
---2.42M
----
----
----
--0.00
-100.00%0.00
--0.00
--10.00
Proceeds from stock option exercised by employees
--31.87K
----
----
----
----
----
----
----
----
----
----
----
Proceeds from issuance of warrants
----
----
--0.00
----
----
----
--0.00
--31.37K
----
----
----
----
Net cash flow from other financing activities
-100.00%0.00
-41.14%-22.66K
184.88%572.17K
-100.16%-18.84K
24125.21%9.67M
-62.59%-16.05K
---674.11K
--11.69M
99.47%-40.25K
19.64%-9.87K
---7.60M
---12.29K
Net cash from non-recurrent financing activities
Net cash from financing activities
-127.30%-1.96M
-557.11%-1.84M
74.16%19.82M
-1.07%11.57M
10491.67%7.18M
-596.99%-280.38K
--11.38M
--11.69M
98.67%-69.11K
-100.83%-40.23K
---5.19M
--4.85M
Net cash flow
Beginning cash balance
26.69%167.31M
30.97%163.77M
-7.25%127.43M
47.29%152.74M
37.30%132.06M
21.38%125.04M
--137.39M
--103.70M
106.37%96.18M
99.12%103.02M
--46.61M
--51.74M
Current period cash flow changes
-17.79%17.01M
-49.64%3.53M
394.30%36.34M
-175.12%-25.31M
175.02%20.69M
202.49%7.01M
---12.35M
--33.69M
169.41%7.52M
-33.29%-6.84M
---10.84M
---5.13M
Effect of exchange rate changes
-175.14%-4.11M
-152.51%-3.33M
5.44%-11.23M
-129.20%-3.84M
197.77%5.47M
189.46%6.34M
---11.88M
--13.13M
-743.85%-5.59M
34.20%-7.09M
---662.52K
---10.77M
Ending cash balance
20.67%184.31M
26.69%167.31M
30.97%163.77M
-7.25%127.43M
47.29%152.74M
37.30%132.06M
--125.04M
--137.39M
189.93%103.70M
106.37%96.18M
--35.77M
--46.61M
Free cash flow
349.07%22.04M
639.84%8.68M
746.38%51.04M
-660.30%-21.06M
-148.29%-8.85M
-60.61%1.17M
---7.90M
--3.76M
485.91%18.33M
135.48%2.98M
---4.75M
--1.27M
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
FAQs
What is operating cash flow?
Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.
How Much Operating Cash Flow Did SBC Medical Group Holdings Inc Generate?
SBC Medical Group Holdings Inc generated 24.67M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.
How Did SBC Medical Group Holdings Inc's Operating Cash Flow Change Year Over Year?
SBC Medical Group Holdings Inc's operating cash flow increased by 19.85% year over year.
What is investing cash flow?
Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.
How Much Does SBC Medical Group Holdings Inc Spend on Capital Expenditures?
SBC Medical Group Holdings Inc spent 2.37M on capital expenditures in the most recent quarter。
What is financing cash flow?
Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.
How Has SBC Medical Group Holdings Inc's Financing Cash Flow Changed?
SBC Medical Group Holdings Inc used 38.29M in financing activities in the latest quarter.
What is free cash flow and why does it matter for SBC?
Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.
What was SBC Medical Group Holdings Inc’s free cash flow in the latest quarter?
Free cash flow was 22.30M reflecting a 29.84% change from the previous year.